| Issue Date | Title | Author(s) |
| 2018 | Causes and timing of mortality and morbidity among late presenters starting Antiretroviral therapy in the REALITY Trial | Post, Frank A.; Szubert, Alexander J.; Prendergast, Andrew J.; Johnston, Victoria; Lyall, Hermione; Fitzgerald, Felicity; Musoro, Godfrey; Musiime, Victor; Chepkorir, Priscilla; Agutu, Clara; Mallewa, Jane; Rajapakse, Chathurika; Wilkes, Helen; Hakim, James; Mugyenyi, Peter; Walker, Sarah; Gibb, Diana M.; Pett, Sarah L. |
| 2018 | The effect of antiretroviral intensification with dolutegravir on residual virus replication in HIV-infected individuals: a randomised, placebo-controlled, double-blind trial | Mallewa, Jane; Szubert, Alexander J.; Mugyenyi, Peter; Chidziva, Ennie; Thomason, Margaret J.; Chepkorir, Priscilla; Melly, Betty |
| 2018-04-10 | Effect of ready-to-use supplementary food on mortality in severely immuno compromised HIV-infected individuals in Africa initiating antiretroviral therapy (REALITY): an open-label, parallel-group, randomised controlled trial | Mallewa, Jane; Szubert, Alexander J; Mugyenyi, Peter; Chidziva, Ennie; Thomason, Margaret J; Chepkorir, Priscilla; Abongomera, George; Baleeta, Keith; Etyang, Anthony; Warambwa, Colin; Melly, Betty; Mudzingwa, Shepherd; Kelly, Christine; Agutu, Clara; Wilkes, Helen; Nkomani, Sanele; Musiime, Victor; Lugemwa, Abbas; Pett, Sarah L; Bwakura-Dangarembizi, Mutsa; Prendergast, Andrew J; Gibb, Diana M; Walker, A Sarah; Berkley, James A |
| 2018-04-10 | Effect of ready-to-use supplementary food on mortality in severely immunocompromised HIV-infected individuals in Africa initiating antiretroviral therapy (REALITY): an open-label, parallel-group, randomised controlled trial. | Mallewa, Jane; Szubert, Alexander J; Mugyenyi, Peter; Chidziva, Ennie; Thomason, Margaret J; Chepkorir, Priscilla; Abongomera, George; Baleeta, Keith; Etyang, Anthony; Warambwa, Colin; Melly, Betty; Mudzingwa, Shepherd; Kelly, Christine; Agutu, Clara; Wilkes, Helen; Nkomani, Sanele; Musiime, Victor; Lugemwa, Abbas; Pett, Sarah L; Bwakura-Dangarembizi, Mutsa; Prendergast, Andrew J; Gibb, Diana M; Walker, A Sarah; Berkley, James A |
| 2016 | Empiric Tuberculosis Therapy versus Isoniazid in Advanced HIV- infected Adult Outpatients Initiating Antiretroviral Therapy: a Multi-Country Randomized Controlled Trial | Lagat, David; Mugyenyi, Peter; Nyirenda, Mulinda; Gupta, Amita |
| 2022-06 | Third-line antiretroviral therapy, including raltegravir (RAL), darunavir (DRV/r) and/or etravirine (ETR), is well tolerated and achieves durable virologic suppression over 144 weeks in resource-limited settings: ACTG A5288 strategy trial | Avihingsanon, Anchalee; Hughes, Michael D.; Salata, Robert; Godfrey, Catherine; McCarthy, Caitlyn; Mugyenyi, Peter |
